Search

Search Results

• MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

  Ibrahim C. Haznedaroglu

  e2014009

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.009

  4069

  PDF: 1564

  HTML: 9214

  Untitled: 288

  Untitled: 195

  Untitled: 181

  Untitled: 173

  Untitled: 197

  Untitled: 352

• TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

  Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni

  e2022073

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.073

  1301

  PDF: 1046

  HTML: 298

• Multiple bone and joint disease in a sickle cell anaemia patient: a case report

  John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari

  e2012023

  2012-05-03

  https://doi.org/10.4084/mjhid.2012.023

  1302

  PDF: 757

  HTML: 1748

• THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

  Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini

  e2016025

  2016-05-01

  https://doi.org/10.4084/mjhid.2016.025

  6400

  PDF: 2165

  HTML: 14073

  Untitled: 210

  figure: 195

• GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

  Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa

  e2021067

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.067

  1529

  PDF: 645

  HTML: 307

• PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

  Suparno Chakrabarti, Somnath Mukherjee

  e2009017

  2009-12-10

  https://doi.org/10.4084/mjhid.2009.017

  863

  PDF: 572

  HTML: 2461

• Multiple myeloma diagnosed by CT-guided rib biopsy after a hemodilute bone marrow aspirate, in a patient with a biclonal pattern on serum protein electrophoresis Multiple Myeloma diagnosed with CT-guided rib biopsy

  Arjeta Cyrbja, Liri Seraj, Shaqir Qerama

  e2026061

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.061

  199

  PDF: 93

  HTML: 49

• IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

  Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica

  e2021062

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.062

  1274

  PDF: 494

  HTML: 179

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2214

  PDF: 1744

  HTML: 559

• Common parasite with uncommon associations

  Sonal Jain, Jasmita Dass, Monica Sharma, Seema Tyagi

  e2011015

  2011-03-29

  https://doi.org/10.4084/mjhid.2011.015

  1537

  PDF: 683

  HTML: 1846

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4511

  PDF: 1752

  HTML: 1112

• AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS

  Pavankumar Tandra, Jairam Krishnamurthy, Vijaya Bhatt, Kam Newman, James O Armitage, Mojtaba Akhtari

  e2013068

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.068

  2242

  PDF: 1221

  HTML: 3885

• IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

  Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi

  e2017010

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.010

  3452

  PDF: 1317

  HTML: 2258

  Fi.1 Gritti.Rambaldi: 218

• Morphologic confounders and CD19 negativity in a case of hairy cell leukemia.

  Pulkit Rastogi, Sreejesh Sreedharanunni, Uday Yanamandra, Man Updesh Singh Sachdeva, Neelam Varma

  e2017033

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.033

  2302

  PDF: 913

  HTML: 1238

• GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

  Laura Breda, Roberto Gambari, Stefano Rivella

  e2009008

  2009-11-16

  1342

  PDF: 432

  HTML: 2975

• TYROSINE KINASE INHIBITORS AND INTERFERON

  Maria Dimou, Panagiotis Panagiotidis

  e2014006

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.006

  2919

  PDF: 1460

  HTML: 3067

  Cover Letter: 221

• Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

  Daniela Taurino, Marco Frigeni, Anna Grassi, Gianluca Cavallaro, Silvia Salmoiraghi, Orietta Spinelli, Alessandro Rambaldi, Federico Lussana

  e2021057

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.057

  1301

  PDF: 522

  HTML: 191

• ATRA induced Reactive Hemophagocytosis: A Case Report

  Monica Sharma, Sanjeev Kumar Sharma, Jasmita Dass, Seema Tyagi

  e2011034

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.034

  1259

  PDF: 612

  HTML: 2886

  ATRA induced Reactive Hemophagocytosis: A Case Report: 209

• PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

  Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli

  e2019015

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.015

  1899

  PDF: 1003

  HTML: 337

• THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

  May Basood, Howard S. Oster, Moshe Mittelman

  e2018046

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.046

  3237

  PDF: 1415

  HTML: 597

• Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

  Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu

  e2025038

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.038

  1087

  PDF: 764

  HTML: 99

• BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

  Roberto Castelli

  e2016030

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.030

  4875

  PDF: 998

  HTML: 1833

• FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

  Andrea Gallamini, Anna Borra

  e2017029

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.029

  3365

  PDF: 1268

  HTML: 2271

• HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

  Mazyar Shadman, Joachim Deeg

  e2014056

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.056

  2091

  PDF: 786

  HTML: 3174

• Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

  Yu Chen, Jin Zhang, wenqiang kong

  e2026005

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.005

  593

  PDF: 476

  HTML: 132

• ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica

  e2010026

  2010-08-31

  https://doi.org/10.4084/mjhid.2010.026

  1422

  PDF: 828

  HTML: 977

• HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

  Anna Maria Testi

  e2022038

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.038

  1250

  PDF: 863

  HTML: 231

• ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

  Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene

  e2014068

  2014-08-28

  https://doi.org/10.4084/mjhid.2014.068

  2058

  PDF: 735

  HTML: 2130

  Untitled: 232

  Untitled: 161

  Untitled: 185

  Untitled: 165

  Untitled: 178

  Untitled: 190

  Untitled: 194

• RECENT ADVANCES IN THE 5Q- SYNDROME

  Andrea Pellagatti, Jacqueline Boultwood

  e2015037

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.037

  2866

  PDF: 1851

  HTML: 3704

  Pellagatti Fig 1: 230

  Pellagatti Fig. 2: 224

• USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

  Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet

  e2010003

  2010-03-26

  https://doi.org/10.4084/mjhid.2010.003

  1145

  PDF: 542

  HTML: 879

• Multiple Myeloma and Paget’s disease with abnormal skull lesions and intracranial hypertension

  Tommaso Caravita, Agostina Siniscalchi

  e2112068

  2012-11-04

  https://doi.org/10.4084/mjhid.2012.068

  1125

  PDF: 684

  HTML: 10848

• CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

  Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori

  e2019048

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.048

  2209

  PDF: 1202

  HTML: 281

• TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

  Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD

  e2022018

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.018

  1932

  PDF: 798

  HTML: 550

• CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira

  e2016024

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.024

  4673

  PDF: 1369

  HTML: 4741

• CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

  omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad

  e2015049

  2015-08-25

  https://doi.org/10.4084/mjhid.2015.049

  1575

  PDF: 901

  HTML: 1000

  figures: 200

  table 1: 199

  table2: 196

  table3: 199

• Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia

  Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi

  e2026003

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.003

  627

  PDF: 542

  Html: 121

• INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

  Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund

  e2009028

  2009-12-28

  1255

  PDF: 632

  HTML: 4429

• A case of severe gastrointestinal toxicity after allogeneic hematopoietic stem cell transplantation: can we improve the evaluation of the “gut fitness“ ?

  Gabriele Magliano, Enrico Morello, Mirko Farina, Vera Radici, Marco Galli, giulia brambilla, Michele Malagola, Domenico Russo, Daniele Avenoso

  e2025054

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.054

  713

  PDF: 487

  HTML: 74

• ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

  Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca

  e2020075

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.075

  1604

  PDF: 1440

  HTML: 557

• ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

  Maria L. Delioukina, Stephen J. Forman

  e2010018

  2010-06-30

  https://doi.org/10.4084/mjhid.2010.018

  1278

  PDF: 802

  HTML: 566

• OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

  Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi

  e2010010

  2010-05-07

  https://doi.org/10.4084/mjhid.2010.010

  1561

  PDF: 810

  HTML: 771

• Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review

  Susmitha Apuri, Kristin Carlin, Edward Bass, Phuong Thuy Nguyen, John Norman Greene

  e2014014

  2014-02-18

  https://doi.org/10.4084/mjhid.2014.014

  3644

  PDF: 1549

  HTML: 4460

  CoverLetter: 193

  Figure1: 205

• ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

  Karim Massaro, Silvia F Costa

  e2015059

  2015-10-15

  https://doi.org/10.4084/mjhid.2015.059

  2180

  PDF: 1012

  HTML: 1766

• Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

  Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez

  e2022013

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.013

  1160

  PDF: 573

  HTML: 228

• CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

  Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi

  e2009030

  https://doi.org/10.4084/mjhid.2009.030

  1335

  PDF: 610

  HTML: 3558

• THALASSAEMIA INTERMEDIA : AN UPDATE

  Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini

  e2009004

  2009-08-17

  1091

  PDF: 452

  HTML: 9457

• Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

  Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan

  e2016050

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.050

  2837

  PDF: 782

  HTML: 1292

  Blood Count trend before and during lenalidomide treatment: 184

  Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 199

• Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin

  Caterina Giovanna Valentini, Valentina Bozzoli, Anna Rita Larici, Luigi Maria Larocca, Giovanni Delogu, Giuseppe Leone, Livio Pagano

  e2012040

  2012-06-18

  https://doi.org/10.4084/mjhid.2012.040

  2014

  PDF: 683

  HTML: 19374

• As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report

  Aylin Canbolat Ayhan, Korhan ozkan, Cetin Timur, Birol Aktaş, Ayse Bahar Ceyran

  e2013043

  2013-06-06

  https://doi.org/10.4084/mjhid.2013.043

  1750

  PDF: 638

  HTML: 1534

  Figure 1: MRI demonstrating Aspergillus synovitis: 193

  Figure 2:MRI demonstrating Aspergillus synovitis: 198

• Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

  Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia

  e2012041

  2012-06-19

  https://doi.org/10.4084/mjhid.2012.041

  1134

  PDF: 764

  HTML: 761